Connect your AI

Innoviva, Inc. INVA Development Regulatory And Royalty — Future Potential Milestone Payable

Similar metrics at other companies

DNTHSecond Development Program — Potential Milestone Payments Due

$3.3M+3.1%

TARSDevelopment and Regulatory Milestone — Milestone payments to be achieved

$67.5M0.0%

TARSDevelopment and Regulatory Milestone — Maximum milestone payments

$20M0.0%

TBPHFuture Royalty Payment Contingencies

$32.8M+5.9%

ANABRepayment Of Advance Future Royalty And Milestones

$12.81M-44.3%

LGNDDevelopment, regulatory, & commercial milestones and tiered royalties — Investments

$375M0.0%

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept inva:FuturePotentialMilestonePayable.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s development regulatory and royalty — future potential milestone payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s development regulatory and royalty — future potential milestone payable?: Innoviva, Inc. (INVA) reported development regulatory and royalty — future potential milestone payable of $20M in Q1 2026.
What does development regulatory and royalty — future potential milestone payable mean?: This metric represents the total estimated future financial obligations owed to third-party partners or licensors upon the achievement of specific development or regulatory milestones. It reflects the contingent liabilities associated with the company's royalty-bearing assets and the cost of maintaining rights to these healthcare products. Monitoring this figure helps investors assess the potential cash outflows required to sustain the company's royalty revenue stream.